CATALYST PHARMACEUTICALS, INC.
Clinical trial NCT05796570 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-09-01 → 2026-08-19 3. enrollment: 37 → 29 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05796570 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-09-01 → 2026-08-19 3. enrollment: 37 → 29 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07225959 updates: 1. completion date: 2027-07-01 → 2027-07-31 2. primary completion date: 2027-07-01 → 2027-07-31
Clinical trial NCT06884267 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-11-03 → 2027-12-11 3. primary completion date: 2027-11-03 → 2027-12-11 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06422143: completion date: 2031-02-12 → 2031-08-15.
Clinical trial NCT06632002 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. start date: 2025-01-02 → 2025-01-14 3. completion date: 2026-05-01 → 2026-05-07 4. primary completion date: 2026-05-01 → 2026-05-07
Clinical trial NCT07645651 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-10-01 → 2026-09-15
Clinical trial NCT06921759 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-07-28
Clinical trial NCT07685808 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-29 → 2026-07-28
Clinical trial NCT06800313 updates: 1. start date: 2025-02-20 → 2025-02-06 2. completion date: 2030-04-01 → 2028-07-11 3. primary completion date: 2028-04-01 → 2028-07-11
Clinical trial NCT07660432 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2027-07-01 → 2026-07-03
Clinical trial NCT06382948: enrollment: 240 → 300 participants.
Clinical trial NCT07707375 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-01 → 2026-07-20
Clinical trial NCT06998069: primary completion date: 2026-06-01 → 2026-12-01.
Clinical trial NCT03355976 updates: 1. completion date: 2026-09-01 → 2026-12-01 2. primary completion date: 2026-06-01 → 2026-10-01
Clinical trial NCT06385275 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 55 → 49 participants 3. enrollment type: ESTIMATED → ACTUAL